Biotechnology Research Services

Biotechnology Research Services

Overview

The 3,600 biotechnology research firms in the US study the use of microorganisms and cellular and biomolecular processes to develop or alter living or non-living materials. Firms develop new biotechnology processes or prototypes of new or genetically-altered products that may be reproduced, utilized, or implemented by various industries. A firm may specialize in a particular field, such as oncology, cardiovascular medicine, or agricultural products. Companies may also specialize in a particular stage of drug development (discovery, pre-clinical, clinical) or offer a full-service model that allows a firm to play a part in each step of the drug approval process.

Inherent Failure

The overall probability that a drug in the discovery and preclinical phases of development will reach the final market is extremely low.

Demand for CRO Services Rises

Demand for contract research services is projected to grow, driven by increases in R&D budgets and a preference towards outsourcing.